Introduction
Development of the vertebrate nervous system is initiated by demarcation of the neurogenic region from the surrounding epidermal region in the embryonic ectoderm (neural induction), which is followed by generation of anteroposterior (AP) pattern within the neurogenic region (neural patterning). The induced new ectoderm tissue exhibits initially anterior neural character (forebrain); subsequent patterning step then specify more posterior neural character (midbrain, hindbrain, spinal cord) (Nieuwkoop, 1952; Slack and Tannahill, 1992) . Recent molecular studies have revealed that a number of signal transducing pathways are involved in neural induction, either positively or negatively, in amphibian and amniote embryos (Wilson and Hemmati-Brivanlou, 1997; Wilson and Edlund, 2001 ). These include Fgf, Wnt and Bmp signaling pathways. Notably, the neural pattering step seems also to include signaling by Fgf (Cox and Hemmati-Brivanlou, 1995; Hongo et al., 1999; Kengaku and Okamoto, 1995; Lamb and Harland, 1995) and Wnt (Kiecker and Niehrs, 2001; McGrew et al., 1995) , in addition to that by retinoic acid (Blumberg et al., 1997; Kolm et al., 1997) . Classic experiments have predicted that patterning signals act in a gradient, with higher signaling level conferring more posterior neural character to the anteriorly induced tissue (Nieuwkoop, 1952; Slack and Tannahill, 1992) .
Among the candidate signaling molecules for neural induction and patterning, Fgf is of particular interest. Fgf can change the developmental fate of Xenopus ectoderm cells in culture from epidermal to neural (Kengaku and Okamoto, 1993) , and induce these cells to express position-specific neural markers along AP axis in a dose-dependent manner, with higher doses eliciting more posterior neural marker genes (Kengaku and Okamoto, 1995) . Furthermore, loss-offunction experiments have shown that Fgf signaling is required for both anterior (Hongo et al., 1999) and posterior (Holowacz and Sokol, 1999; Pownall et al., 1996; Ribisi et al., 2000) neural development, as judged by expression of positional marker genes. However, a recent report indicates that dosedependent Wnt signaling is both necessary and sufficient for AP neural patterning (Kiecker and Niehrs, 2001) , although another report indicates that Wnt signaling posteriorizes neural tissue through elevating the level of Fgf signaling (Domingos et al., 2001) . Thus, the precise role of each of these signaling pathways for the establishment of AP neural pattern and how they are integrated with signaling in the preceding neural induction step is still not clear.
To address these questions, we may need not only loss-or gain-of-function experiments, but also an approach to directly identify cis-acting sequence elements in positional marker genes, which respond to the neural patterning signals. In this study, we investigated the nature of the Fgf response element (FRE) in a posterior marker gene, Xcad3 (Northrop and Kimelman, 1994) . Xcad3, a Xenopus caudal homologue encoding a homeodomain transcription factor, lies downstream of Fgf signaling and functions as an upstream activator of several Hox genes that regulate posterior embryonic development (Isaacs et al., 1998; Northrop and Kimelman, 1994; Pownall et al., 1996) , as has been implicated for some members of the caudal gene family of other vertebrate species (Cdx genes in mammals and chicken) (Deschamps et al., 1999) .
We have isolated an Xcad3 genomic clone containing regulatory elements that drive Xcad3 expression in the posterior neural tube in response to Fgf signaling. We provide evidence that FREs of Xcad3 are widely dispersed in the first intron and we demonstrate that these multiple FREs comprise Ets-binding and Tcf/Lef-binding motifs (EBMs and TLBMs) that lie in juxtaposition. Functional analysis shows that Ets family transcription factors are indeed involved in the Fgf response of Xcad3 activation. This indicates that Xcad3 is directly targeted by Fgf signaling, as Ets proteins are nuclear effectors of Fgf/Ras/mitogen-activated kinase (Mapk) pathway (Wasylyk et al., 1998) . By contrast, XTcf3, a nuclear effector of Wnt/β-catenin pathway (Molenaar et al., 1996) , functions as a repressor of Xcad3 (Nusse, 1999) . Furthermore, Sox2, a Sry-related transcription factor that shares the cognate DNA-binding motif with Tcf/Lef family members (Kamachi et al., 2000) is shown to cooperate with Ets proteins, possibly by competing with XTcf3 for TLBMs in the composite FREs. Direct interaction of these proteins with some EBMs and TLBMs were demonstrated in gel mobility shift assays. Sox2 is de-repressed in the neurogenic region by Bmp antagonists during the neural induction step (Mizuseki et al., 1998a) . Our results thus indicate that signaling pathways of Bmp, Fgf and Wnt are integrated on the FREs to regulate the expression of Xcad3 in the posterior neural tube during neural patterning.
Materials and methods
Cloning of Xcad3 genomic DNA Xenopus genomic library (Stratagene) was screened with a probe containing 383 bp (from the translation start site to 383) cDNA (Northrop and Kimelman, 1994) in Xcad3, which was prepared by PCR from cDNA synthesized from Xenopus neurula stage mRNA. The transcription initiation site was determined by 5′ RACE using the 5′-Full RACE Core Set (TaKaRa).
Plasmid construction
The 5′ flanking and first intron of Xcad3 were subcloned into a luciferase reporter plasmid pGL3-Basic Vector (Promega), separately or in combination. The 5′ flanking sequence was inserted upstream of the luciferase coding sequence, although the first intron sequence was inserted downstream as follows. An EcoRI fragment of a genomic clone (-1741 to +389) was subcloned into the EcoRI site of pBluscript II SK-(Stratagene); sequence -1741 to +174 (one nucleotide upstream of the translation start site) was amplified by PCR and cloned into blunted NcoI site of pGL3-Basic Vector. SacI (in the phage arm)-EcoRI fragment (-7000 to -1741) was then cloned into the SacIEcoRI site of pGL3-Basic that contained 5′ fragment -1741 to +175. The first intron sequence was amplified by PCR and cloned into the BamHI site of pGL3-Basic. To generate chimeric constructs with SV40 sequences, pGL3-Promoter Vector that contains SV40 promoter sequence upstream of luciferase sequence, or pGL3-Enhancer Vector that contains SV40 enhancer sequence downstream of it was used instead of pGL3-Basic Vector. To generate constructs containing 5′ flanking and intronic sequence deletion, respective PCR fragments were cloned into pGL3-Basic as above. For a GFP reporter plasmid, the luciferase-coding region was removed from pGL3 vector sequence by NcoI-XbaI digestion and replaced by a NcoI-XbaI fragment from pEGFP-N3 (Clontech), containing the EGFP-coding sequence. Mutations of EBMs and TLBMs were introduced by Ex-Site mutagenesis kit (Stratagene). The entire or deleted coding sequences of XEts1 (Meyer et al., 1997) , XER81 (Chen et al., 1999; Munchberg and Steinbeisser, 1999) , human ELK1 (Chen et al., 1999) , XTcf3 (Molenaar et al., 1996) , XLef1 and β-catenin (Molenaar et al., 1996) were amplified by PCR and subcloned into pSP64T. Vp16-XTcf3 was as published (Kim et al., 2000) . Sox2-EnR was made by in-frame C-terminal fusion of the Drosophila engrailed repressor region (Conlon et al., 1996) to Sox2. Sox2, Sox2 BD(-) and SoxD BD(-) were kindly provided by Y. Sasai (Kishi et al., 2000; Mizuseki et al., 1998a; Mizuseki et al., 1998b) .
Microinjection and transgenesis
Microinjection of reporter and internal standard plasmids with or without synthetic mRNA of various transcription factors was performed as previously described (Hongo et al., 1999) . Injected plasmids were adjusted to the same on a molar base and they were injected at 3×10 -18 moles in 1.6 nl/blastomere of eight-cell stage Xenopus embryos. Transgenic embryos were generated as described (Kroll and Amaya, 1996) .
Microculture and quantitative RT-PCR
Injected or uninjected Xenopus gastrula embryos were used. Methods for culturing ectoderm cells were essentially as previously described (Kengaku and Okamoto, 1993) . RNA was extracted from 20 cultures for each experimental point and subjected to quantitative RT-PCR as previously described (Hongo et al., 1999; Kengaku and Okamoto, 1995) .
Luciferase assay
The luciferase assay was performed using the Dual-Luciferase Reporter Assay System (Promega), in which firefly luciferase in pGL3 was used for the reporter gene assay, whereas Renilla luciferase in the internal standard plasmid pRL-CMV was used for normalization. After a group of injected embryos or cultures were incubated up to the desired stage, they were homogenized in Passive Lysis buffer (Promega). For the embryonic cell culture assay, half the culture medium in each culture well was replaced by 2×Passive Lysis buffer and 20 cultures were collected and homogenized for each experimental point. The lysate was centrifuged at 18,000 g for 1 minute at 4°C. The clear supernatant was assayed with firefly luciferase substrate and Renilla luciferase substrate separately to avoid possible interference. Each luciferase activity was measured three times, and the mean value was used. All of the injection experiments were carried out at least three times and gave reproducible results. One representative experiment was shown for each figure.
Gel mobility shift assay V5-epitope-tagged XTcf3, Sox2 and XEts1 proteins were made by in vitro translation with a rabbit reticulocyte lysate (Promega), and gel mobility shift assays were performed as described (Huang et al., 1995) . DNA fragments used as probes were 3′ end-labeled with digoxygenin-11-ddUTP according to the manufacturer's recommendations (Roche Diagnostics; DIG Gel Shift Kit). Supershifts were generated by adding 1 µl of monoclonal antibody directed against V5 epitope (Invitrogen). DNA-protein complexes were separated by electrophoresis through 3.5% polyacrylamide gel containing 0.5×TBE and 2.5% glycerol. Gels were further processed according to the manufacturer's recommendation (Roche Diagnostics; DIG Gel Shift Kit).
Results
5′ flanking and intronic sequences direct Fgfdependent Xcad3 expression in the posterior neural tube By screening a Xenopus genomic library with an Xcad3 cDNA probe, we obtained four overlapping Xcad3 clones that Fgf response elements of Xcad3 encompassed a 5′ flanking sequence (about 7000 bp), full coding sequence and a 3′ flanking sequence (about 13,000 bp), collectively. A comparison of the genomic sequence with cDNA sequence (Northrop and Kimelman, 1994) showed that Xcad3 gene had two introns within the coding sequence, 3946 bp (intron1) and 291 bp (intron2) in length, respectively (Fig.  1A) . The overall structures of the Xcad3 gene was similar to that of human and mouse Cdx genes, as inferred from draft and finished sequences deposited in NCBI database.
We asked whether the Xcad3 genomic clone contains regulatory elements that drive Xcad3 expression in the posterior neural tube (spinal cord) under the control of Fgf signaling. For this, we subcloned the 5′ flanking region and intron1 into a luciferase reporter plasmid pGL3, separately or in combination (Fig. 1B) . These constructs were injected into the prospective anterior brain or posterior neural tube region of eightcell stage embryos (Hirose and Jacobson, 1979 ) (AB or PNT in Fig. 1B ). We found that robust luciferase activity was induced only when the reporter construct contained both 5′ flanking and intron1 sequences, and injected into the PNT site. Reporter constructs containing either 5′ flanking or intron1 sequence alone were not as effective as the full construct irrespective of the site of injection. In several series of experiments, the spatial specificity (PNT versus AB) in the reporter activities reached more than 10-fold reproducibly.
To locate regulatory elements in the 5′ flanking sequence, deletion analysis was carried out using the luciferase assay system. We found that a truncation down to -185 (relative to the transcription initiation site) did not largely affect the spatial specificity and the extent of luciferase expression (details not shown, but see Fig. 1D for an example).
We then tested the ability of the 5′ immediate upstream sequence and intron1 to regulate spatiotemporal expression pattern of Xcad3. For this we replaced luciferase with green fluorescent protein (GFP) as a reporter, and generated transgenic embryos carrying the GFP construct (-185/GFP/intron1 as depicted in Fig. 1C ). GFP expression was first detected at stage 11 in the marginal zone, the prospective mesoderm region. During neurula and tail bud stages, GFP was expressed primarily in the posterior of the developing neural tube (Fig. 1C ). This spatiotemporal expression pattern of GFP was consistent with that of the endogenous Xcad3 as determined by in situ hybridization, except for a stripe of GFP expression above the eye (Northrop and Kimelman, 1994) . The ectopic expression may reflect a high level of Fgf signals at the midbrain/hindbrain boundary (Christen and Slack, 1997; Tannahill et al., 1992) . It is likely that additional elements would be necessary to suppress GFP expression in this region.
We further asked whether the reporter activity induced by the 5′ upstream elements and intron1 of Xcad3 was dependent on Fgf signaling. For this, mRNA encoding a dominantnegative Xenopus Fgf receptor type 4a (∆XFgfR4a) (Hongo et al., 1999) were co-injected into the PNT site at the eight-cell stage. We found that overexpression of ∆XFgfR4a caused a strong suppression of luciferase activity induced by -7000/LUC/intron1 or -185/LUC/intron1 construct (Fig. 1D) . Although the extent of suppression varied somewhat in several series of experiments, it averaged more than 80%.
Collectively, our results indicate that regulatory elements present in 5′ upstream and intron1 sequences are sufficient to drive Xcad3 expression in the posterior neural tube and they include FREs, which are indispensable for Xcad3 expression. sequences. Xcad3/LUC reporter constructs indicated left of the histogram were injected into the PNT site together with mRNA (100 pg/blastomere) encoding ∆XFgf-4a or d59 (a control inactive version of ∆XFgfR-4a). The d59 lacks a stretch of 59 amino acids that is required for dimerization with a wild-type receptor subunit (Amaya et al., 1991) . Luciferase activities were analyzed and presented as in B.
High-dose-dependent FREs are present in intron1
Fgf can induce Xenopus gastrula ectoderm cells in culture to express position-specific neural marker genes along the anteroposterior axis in a dose-dependent manner; with lower doses eliciting more anterior marker genes such as XeNK2 or En2 and higher doses more posterior marker genes such as XlHbox1 (Hoxc6) or XlHbox6 (Hoxb9) (Kengaku and Okamoto, 1995) . Indeed endogenous Xcad3 was activated in considerably higher Fgf dose range than En2, when examined in the embryonic cell culture assay ( Fig. 2A,B) .
We then asked whether FREs that were supposed to be located within the 5′ flanking sequence and/or intron1 of Xcad3 exhibited such a high dose dependence on Fgf. Experimental design is shown in Fig. 2C . It was found that the Fgf doseresponse profile for luciferase activity of -7000/LUC/intron1 construct coincided very well with that for transcriptional activity of endogenous Xcad3 (Fig. 2D) . Similar results were obtained with reporter constructs containing truncated 5′ upstream sequences such as -185/LUC/intron1, but those containing either 5′ sequences or intron1 alone failed to respond to bFgf (not shown).
Where, then, are the FREs of Xcad3, in the 5′ upstream sequence or in intron1? To answer this question, we prepared chimeric constructs in which the 5′ sequence and intron1 were replaced with SV40 promoter and enhancer sequences, respectively, as depicted in Fig. 2E ,F. These SV40 elements were used to enhance reporter activities, as 5′ sequence or intron1 alone could not induce sufficient reporter activities for quantitative analysis, as shown in Fig. 1B . We found that a chimeric construct containing intron1 (SV40 promoter/Luc/ intron1) exhibited a dose-dependent response to Fgf (Fig. 2E,  ᭡) , but any other constructs examined including -7000/LUC/ SV40 enhancer, SV40 promoter/LUC/SV40 enhancer (Fig. 2F , , ᭢), or -185/LUC/SV40 enhancer (not shown) did not show such dose-dependence on Fgf. However, the Fgf dose-response profile of the active construct (SV40 promoter/LUC/intron1) did not coincide well with that of the intact construct ( Fig. 2E ; ᭹, -7000/LUC/intron1) in this and other series of experiments. It is likely that the FREs of Xcad3 are primarily located within the intron1 but their interaction with 5′ upstream elements through specific transcription factors is required to mediate the proper dose-dependent response of Xcad3 to Fgf.
FREs comprise Ets-binding and Tcf/Lef-binding motifs
To identify the FREs in the intron1, deletion analysis was carried out using the embryonic cell culture assay. A control construct containing the full-length intron1 exhibited at least 20-fold activation of the reporter activity by the addition of bFgf as exemplified in Fig. 3A (i). Several series of experiments showed that the 5′-most 1200 bp and 3′-most 600 bp sequences were dispensable (not shown). Further serial deletion of 1100 bp from the 5′ side resulted in progressive loss of Fgf responsiveness [ Fig. 3A (ii-iv)]. Similar gradual change was reproducibly observed by deleting this region consecutively, indicating that multiple FREs are distributed within it (domain 1 in Fig. 3A) . Notably, the sequence 3′ to the domain 1 still retained Fgf responsiveness that amounted to about 5-fold activation as exemplified in Fig. 3A(iv) . Indeed, several series of deletion experiments from the 3′ side [ Fig. 3A(v) , (vi), for example] showed that there was another domain that contained FREs (domain 2 in Fig. 3A ). Progressive loss of Fgf responsiveness by serial deletions within the domain 2 was exemplified in Fig. 3B (see below for more detail). These results indicate that FREs are not localized in a narrow region within intron 1 but rather widely dispersed throughout it, conferring the full Fgf responsiveness to intron 1 in a coordinated manner.
To search for candidate DNA motifs that constitute FREs, sequence analysis was carried out on intron 1. We noticed that a number of Ets-binding motifs (EBMs) were present throughout intron1 (Fig. 3A, blue triangles) . The EBM (consensus sequence A/C GGA A/T) (Sharrocks et al., 1997) is known to serve as the binding site for the Ets family of transcription factors that are nuclear effectors of the Fgf/Ras/ Mapk pathway (Wasylyk et al., 1998) . In Xenopus embryos, this pathway represents a major transducing pathway from Fgf ligand to its nuclear targets (LaBonne and Whitman, 1997; MacNicol et al., 1993; Weinstein et al., 1998; Whitman and Melton, 1992) . Interestingly, many of the EBMs in domains 1 and 2 were in the proximity of Tcf/Lef binding motifs (TLBM; consensus sequence CTTTGA/TA/T) (van de Wetering et al., 1997) , as illustrated in Fig. 3A (red triangles) and Fig. 4A . The TLBM serves as the binding site for the Tcf/Lef family of transcription factors, nuclear targets of the Wnt/β-catenin pathway in Xenopus embryos (Molenaar et al., 1996) .
Consecutive deletion targeting some of TLBMs and EBMs in domain 2 resulted in a progressive reduction of Fgf responsiveness (Fig. 3B) . We then asked whether these EBMs and TLBMs in intron 1 indeed constitute FREs that mediate the transcriptional response to Fgf. For this, we introduced various combinations of mutations into EBMs or TLBMs in domain 2* that included all possible EBMs and TLBMs around domain 2 (Fig. 3A, Fig. 4A ), and examined Fgf dose-response profiles of these mutated constructs. Among an extensive series of experiments, typical ones are presented in Fig. 4B ,C. Introduction of mutations into an increasing number of EBMs resulted in a progressive loss of Fgf responsiveness, reaching nearly complete elimination by mutagenesis of all possible 
(B,C) Mutational analysis of EBMs (B) and TLBMs (C).
Reporter constructs examined contain the domain 2* fragments that carry various combinations of mutations in EBMs or TLBMs, as indicated to the right of each graph (E1, 3 means that EBM1 and EBM3 are mutated). Mutations were introduced as follows: GAA to agA in E1, 2 and 4; TCC to ctC in E3 and 5; ATCCT to gTCga in E6; TTTGT to Tcgag in T1; TCAAA to TagAc in T2; TCAAAGG to Tgtcgac in T3; CTTTG to gaaTt in T4. Reporter activities of mutated constructs were analyzed as in Fig. 3 , except that ectoderm cells were cultured in the absence or presence of increasing concentrations of bFgf. EBMs in domain 2* (Fig. 4B) . Similar gradual loss of Fgf responsiveness was obtained by mutating an increasing number of TLBMs (Fig. 4C) . Our results indicate that both EBMs and TLBMs are required for conferring Fgf responsiveness to domain 2*. By extrapolating from these results, one might expect that EBMs and TLBMs in domain 1, which lie in juxtaposition, are also required for its responsiveness to Fgf. Although this issue has yet to be confirmed, our data strongly suggest that EBMs and TLBMs are components of FREs in intron 1.
Ets transcription factors mediate the response of Xcad3 to Fgf
We next explored the transcription factors that interact with the FREs of Xcad3 to mediate the Fgf response. Obvious candidates are Ets family and Tcf/Lef family proteins. Notably, transcripts of some of the Ets genes including Ets1, Ets2 (Meyer et al., 1997) and ER81 (Chen et al., 1999; Munchberg and Steinbeisser, 1999) as well as that of XTcf3 (Molenaar et al., 1996) are expressed in early Xenopus embryos. These transcription factors would act cooperatively through binding to respective motifs in the composite FREs.
We first assessed the functional role of Ets proteins, as they are potential nuclear effectors of the Fgf/Ras/Mapk signal transducing pathway (Wasylyk et al., 1998) . A mRNA encoding a dominant-negative form of Xenopus Ets1 (dnXEts1), ER81 (dnXER81) or human Elk1 (dnElk1) was co-injected with a reporter construct. These dominant-negative constructs lack the N-terminal (dnXEts1, dnXER81) or C-terminal (dnElk1) regions of the respective wild-type proteins, which include the activation domain (Fig. 5, bottom right) . These mutants thus mainly comprise the DNA-binding ets domain, thereby potentially competing with endogenous Ets proteins for the EBMs (Wasylyk et al., 1994) . Overexpression of dnElk1 and dnEts1 to a lesser extent caused a suppression of the response of the reporter construct to Fgf, while that of dnXER81 did not suppress the response (Fig. 5A) . Increasing the amount of coinjected mRNA suppressed more effectively the Fgf response for dnEts1, but not for dnXER81 (not shown).
These results show that functional activity of endogenous Ets proteins are required for the Fgf response of Xcad3. However, they do not necessarily imply that the Elk1-type and Ets1-type but not ER81-type proteins are responsible for the response, as Ets proteins have overlapping DNA binding specificities (Wasylyk et al., 1994) . Indeed, when the effects of overexpression of the wild type Ets proteins were examined, XEts1 and XER81 were shown to more effectively activate the reporter gene than Elk1 (Fig. 5B) . Furthermore, the wild-type XEts1 and XER81 could reverse the suppression of the Fgf response caused by dnElk1 (Fig. 5C ) or dnXEts1 (not shown).
Collectively, our results indicate that some of the Ets transcription factors are involved as activators in the response of Xcad3 to Fgf. It is highly likely that these Ets proteins bind to EBMs in composite FREs in intron 1, and that Fgf signaling enhances their ability to activate transcription by phosphorylating them through Mapk.
XTcf3 represses Fgf response of Xcad3
We next assessed the functional role of XTcf3, a nuclear target of the Wnt/β-catenin pathway, using a dominant-negative XTcf3 (dnXTcf3) construct. dnXTcf3 lacks the N-terminal region that is required for binding of β-catenin, a co-activator of XTcf3, but retains the ability to bind its cognate DNA motif, thereby abrogating transcriptional activation by the endogenous β-catenin-XTcf3 complex (Molenaar et al., 1996) . In embryonic cell culture assays, overexpression of dnXTcf3 resulted in a suppression of the response to Fgf of a reporter construct in a dose-dependent manner (Fig. 6A) . Surprisingly, however, overexpression of wild-type XTcf3 also caused a profound suppression of the Fgf response instead of an activation (Fig. 6B) . This was unexpected, because Wnt signaling was suggested to be involved in activation of posterior neural genes (Kiecker and Niehrs, 2001; McGrew et al., 1995) and we had anticipated that XTcf3 functioned as an activator of Xcad3 by binding β-catenin. It should be noted, however, that XTcf3 has also been shown to function as a transcriptional repressor instead of an activator by binding co-repressors such as Groucho or XCtBP (Brannon et al., 1999) in place of β-catenin. Overexpression of XLef1, another Tcf/Lef family member that lacks the repressing function of XTcf3, but retains the activating function by binding β-catenin (Brannon et al., 1999; Molenaar et al., 1998) had no effect on the Fgf response (Fig. 6C) . It is possible that the endogenous pool of β-catenin is considerably smaller compared with those of XCtBP, Groucho or other co-repressors in Xenopus ectoderm cells, and XTcf3 (VP16-dXTcf3) may act primarily as a repressor in these cells. Indeed, overexpression of β-catenin itself or a mutant construct in which the VP16 activation domain was fused to truncated XTcf3 counteracted the repressing action of endogenous XTcf3 (Kim et al., 2000) : in embryonic cell culture assays, they induced robust luciferase activity (Fig. 6C,D) . By contrast, overexpression of Wnt8 protein, which would facilitate endogenous β-catenin to complex with XTcf3 (Domingos et al., 2001; Molenaar et al., 1996) did not affect the Fgf response (not shown). Collectively, our results indicate that XTcf3 functions primarily as a repressor of Xcad3. This raises the possibility that Ets proteins overcome this repression by cooperating with other transcription factors that bind to TLBMs in place of XTcf3.
Sox2 is involved as the co-activator in the Fgf response of Xcad3
It has been shown that signaling mediated by Sox2, a Sryrelated transcription factor, is required for the expression of Hoxb9, a downstream target of Xcad3 (Isaacs et al., 1998) , in the posterior neural tube (Kishi et al., 2000) . Notably, Sox2 is a member of the Sox family proteins, which share a DNA-binding high-mobility group (HMG) domain with Tcf/Lef family proteins (Kamachi et al., 2000) . The cognate motif of Sox2 (CA/TTTGTT) (Kamachi et al., 2000) is accordingly very similar to that of Tcf/Lef proteins (CTTTGA/TA/T) (van de Wetering et al., 1997) . This raises the possibility that Sox2 competes with XTcf3 for TLBMs to activate Xcad3 in cooperation with Ets proteins, which leads to upregulation of Hoxb9. Indeed, a combination of Sox2 and bFgf was shown to activate posterior neural genes, including Hoxb9 in the animal cap assay (Mizuseki et al., 1998a) .
Possible involvement of Sox2 in the Fgf response of Xcad3 was examined in the embryonic cell culture assay using a dominant-negative version of Sox2 in which the engrailed repressor domain was fused with Sox2 (Sox2-EnR) (Conlon et al., 1996) . Overexpression of Sox2-EnR resulted in a suppression of the Fgf response of a reporter construct containing the full-length of intron 1 (Fig. 7A) . By contrast, overexpression of wild-type Sox2 caused an activation of the response (Fig. 7B) . Similar suppression by Sox2-EnR and activation by wild-type Sox2 were observed with a reporter construct containing the well characterized domain 2* fragment (Fig. 4A ) and wild-type Sox2 counteracted the suppression caused by Sox2-EnR (Fig.  7C) .
Sox proteins often pair with specific partner factors to regulate target gene transcription (Kamachi et al., 2000) . This led to the idea that a mutant construct in which the DNAbinding HMG domain of a Sox protein was deleted could act as a dominant-negative version by competing with the endogenous Sox protein for a specific partner factor (Conlon et al., 1996; Kishi et al., 2000) . Indeed, such a dominantDevelopment 130 (20) Research article negative version of Sox2 [Sox2 BD(-)] was successfully used to downregulate Hoxb9 in the posterior neural tube, whereas a similar dominant negative version of SoxD, another Sox family protein that was expressed in the neuroectoderm (Mizuseki et al., 1998b) , failed to suppress Hoxb9 expression (Kishi et al., 2000) . In the present embryonic cell culture assays, overexpression of Sox2 BD(-), but not of SoxD BD(-) effectively suppressed the Fgf response of Xcad3 as expected (Fig. 7D) .
Collectively, our functional analysis shows that endogenous Sox2 is required for the Fgf response of Xcad3. The most plausible partner factors of Sox2 are Ets proteins, which are also known to require interaction with partner factors to direct signals to specific target genes (Wasylyk et al., 1998) . It is highly likely that Sox2 competes with XTcf3 for TLBMs in the composite FREs and cooperate with Ets proteins that bind to adjacent EBMs. To test this idea, an intronic fragment containing one EBM and two TLBMs (overlined in Fig. 4A ; probe T2/E4/T3 in Fig. 8A ) was examined for its ability to interact with the XTcf3, Sox2 and XEts1 proteins in the gel mobility shift assay. V5-tagged XTcf3 alone shifted the end-labeled probe, yielding three bands (bands 1, 2 and 3 in Fig. 8A , lane 2). All the three bands were supershifted by antibody against V5-epitope (lane 3) and competed by a 125-fold molar excess of the unlabelled probe (lane 4). When the two TLBMs in the probe were mutated (probe E4), no bands emerged (lane 5), but mutation in either TLBM3 (probe T2/E4) or TLBM2 (probe E4/T3) alone gave rise to two bands that co-migrated with bands 1 and 3 (lane 6 and 8), respectively. All these bands were supershifted by the anti-V5 antibody (lane 7 and 9). These results indicated that band 3 was derived from binding of XTcf3 to either TLBM2 or TLBM3, while band 2 was derived from binding of XTcf3 to both motifs. Band 1 was probably formed by binding of multimerized XTcf3 to these motifs. Binding of XTcf3 to TLBMs appeared to be competed by the presence of an increasing amount of Sox2 in the binding reaction (lane 10 to 12). V5-tagged Sox2 alone gave rise to a single band (lane 13), that was abolished by the anti-V5 antibody (lane 14), and did not emerge with the probe E4 (lane 15). We could not detect binding of Ets proteins used in this study with the wild-type probe, but we found that XEts1 was capable of binding to the TLBM3-mutated probe (band 5; lane 2 in Fig. 8B ) to which Sox2 also bound (band 6; lane 1). XEts1 and Sox2 proteins appeared to form a ternary complex with this mutated probe (band 4; lane 3), which was supershifted by the anti-V5 antibody (lane 4). These observations strongly support the idea of the direct regulatory function of XTcf3, Sox2 and XEts1 proteins in the Fgf response of Xcad3.
We finally asked whether the reporter gene we used (-546/LUC/intron1) was a direct target of Fgf signaling; that is, whether the regulation of the reporter gene by Fgf involved additional intermediates. For this, we cultured ectoderm cells that had been injected with the reporter construct in the presence of bFgf alone or bFgf with the protein synthesis inhibitor cycloheximide (CHX). The concentration of CHX used in this experiment (10 µg/ml) produced more than 90% reduction in translation as previously reported (Isaacs et al., 1998) . A high dose of bFgf induced the reporter gene expression in the embryonic cell culture assay within 1.5 hours, even in the presence of CHX (Fig. 9A) . The extent of expression obtained in the presence of CHX was comparable to that in the absence of CHX, indicating that the intron 1 in the reporter construct was an immediate early target of Fgf signaling.
Discussion

Integration of multiple signaling pathways on FREs of Xcad3
We show that FREs are widely dispersed in intron1 of Xcad3. The reporter constructs containing the FREs exhibit high dose dependence on Fgf similar to that shown for endogenous Xcad3, when examined in the embryonic cell culture assay. Sequence and mutagenesis analyses reveal that these multiple FREs comprise EBMs and TLBMs that lie in juxtaposition. The EBM is known to serve as the binding site for Ets family transcription proteins. An end-labeled probe, either wild type or mutated, was incubated with XTcf3 or Sox2, or with a combination of both proteins in A, and with Sox2 or XEts1, or with a combination of both proteins in B, as indicated in diagrams above. All proteins were tagged with a V5 epitope and made by in vitro translation. Probe T2/E4/T3: an intronic DNA fragment containing TLBM2, 3 and EBM4 (overlined in Fig. 4A ). Probe E4: TLBM2 and 3 mutated. Probe T2/E4: TLBM3 mutated. Probe E4/T3: TLBM2 mutated. Mutations were introduced as described in Fig. 4 . Unlabeled probe (competitor) or antibody against V5 epitope was added as indicated in the diagrams.
factors that are nuclear effectors of the Fgf/Ras/Mapk pathway (Wasylyk et al., 1998) . Indeed, functional and physical analyses show that Ets proteins are involved in the Fgf response of Xcad3 as transcriptional activators, and that Xcad3 is directly targeted by the Fgf signaling pathway. This conclusion is consistent with the previous observation that Fgf could induce Xcad3 expression in the animal cap assay within 2 hours of its addition and even in the presence of the protein synthesis inhibitor cycloheximide, which indicates that Xcad3 is an immediate early target of Fgf signaling (Isaacs et al., 1998) .
TLBMs could serve as the binding sites for Tcf/Lef family transcription factors that are nuclear effectors of the Wnt/β-catenin pathway (Molenaar et al., 1996) . We had anticipated that XTcf3 functioned as a co-activator of Ets proteins, as Wnt signaling was suggested to be involved in activation of posterior neural genes (Kiecker and Niehrs, 2001; McGrew et al., 1995) . Surprisingly, however, functional analysis reveals that XTcf3 acts as a repressor of Xcad3. Our data suggest that the endogenous pool of β-catenin in ectoderm cells is considerably smaller compared with that of XTcf3 co-repressors such as XCtBP and Groucho. This in turn implies that Wnt signaling could activate Xcad3 expression in embryonic cells, when they were provided with larger pool of β-catenin. Marginal zone cells of the early gastrula embryo, where Xcad3 is initially expressed, are among such candidate cells, as a relatively large amount of β-catenin is translocated into the nucleus in these cells (Schohl and Fagotto, 2002) . Recently, an mutant function of Tcf3 as a repressor is revealed in the zebrafish headless mutant that carries a mutation in Tcf3 (Kim et al., 2000) . In this mutant, expression of midbrain-hindbrain boundary genes such as En2 and Pax2 are de-repressed in more anterior neural region, leading to severe head defects. It would be interesting to know whether similar anterior expansion is seen in Cdx gene expression in this mutant.
Sox2 is de-repressed by Bmp antagonists in the neurogenic region of ectoderm during neural induction (Mizuseki et al., 1998a) . We show that Sox2 which shares a cognate DNA bindings motif with Tcf/Lef family members, is required as a co-activator for the Fgf response of Xcad3. Sox2 is likely to compete with XTcf3 for TLBMs in the composite FREs to cooperate with Ets proteins that bind to adjacent EBMs. Physical analysis supports this idea. Both Sox and Ets family transcription factors interact with specific partner factors to direct signals to target genes (Kamachi et al., 2000; Wasylyk et al., 1998) , but direct partnership between them has not been reported. Collectively, our results indicate that signaling pathways of Fgf, Bmp and Wnt are integrated on the FREs to regulate the expression of Xcad3 in the posterior neural tube through positively acting Ets and Sox proteins and negatively acting Tcf protein (Fig. 9B ).
Fgf as a morphogen
Ets (Chen et al., 1999) and Sox (Mizuseki et al., 1998a; Mizuseki et al., 1998b) proteins are ubiquitously expressed in the neurogenic region during gastrula stages when neural patterning is initiated. Posteriorly biased Xcad3 expression could, therefore, be primarily due to similarly biased expression of Fgf proteins. Indeed, several Fgf genes are activated in the posterior ectoderm and mesoderm during late gastrula and early neural stages (Christen and Slack, 1997; Isaacs et al., 1992; Tannahill et al., 1992) . In this and previous studies (Kengaku and Okamoto, 1995) , we have shown that Fgf can induce gastrula ectoderm cells to express position-specific neural marker genes along the AP axis in a dose-dependent manner, with higher doses eliciting more posterior neural genes. Interestingly, functional analysis indicated that Soxmediated signaling (Kishi et al., 2000; Mizuseki et al., 1998b) and Fgf signaling (Hongo et al., 1999) were also required for the expression of anterior neural genes. These studies raise the possibility that regulatory mechanisms underlying the transcriptional activation of anterior neural genes possess common features with that for Xcad3 activation except for higher sensitivity to Fgf. Differential sensitivity of positionspecific neural genes to Fgf would then imply that Fgf acts as a morphogen during neural patterning (Kengaku and Okamoto, 1995) . To explore this issue, we need to identify cis-elements in anterior neural genes, and the present embryonic cell culture assay system will be useful for this purpose.
We thank Dr D. Weinstein for critical reading of this manuscript and Mrs A. Umeda for technical assistance. . In A, experimental design was essentially the same as in Fig. 2C , except for the following changes. A reporter construct (-546/LUC/intron1) was injected into animal blastomeres of eight-cell stage embryos. Ectodermal cells at stage 10 were cultured for 30 minutes with or without 10 µg/ml cycloheximide and then for an additional 1.5 hours with or without bFgf (10 ng/ml). The transcriptional levels of the reporter gene (luciferase-coding portion) were analyzed by RT-PCR.
